2011
DOI: 10.1016/j.nbd.2011.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
75
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(80 citation statements)
references
References 85 publications
5
75
0
Order By: Relevance
“…9,10 GM-CSF, however, has since been demonstrated to also have a function in the central nervous system because GM-CSF can cross the blood-brain barrier 11,12 and both GM-CSF and its receptor are expressed by various brain cells. 13,14 GM-CSF has also been reported to have neuroprotective effects in animal models of Alzheimer disease, 15 Parkinson disease, 16 stroke, 14,17 spinal cord injury, [18][19][20] and stab wound-induced brain injury, 21 all of which bear pathological similarities to TBI. Furthermore, a post-mortem study of human brain tissue taken from acute TBI victims reported elevated levels of inflammatory cytokines including GM-CSF, 22 and the modulation of GM-CSF in animal studies has been shown to alter other inflammatory cytokines involved in TBI, including tumor necrosis factor-alpha and interleukin-1 beta.…”
Section: Introductionmentioning
confidence: 99%
“…9,10 GM-CSF, however, has since been demonstrated to also have a function in the central nervous system because GM-CSF can cross the blood-brain barrier 11,12 and both GM-CSF and its receptor are expressed by various brain cells. 13,14 GM-CSF has also been reported to have neuroprotective effects in animal models of Alzheimer disease, 15 Parkinson disease, 16 stroke, 14,17 spinal cord injury, [18][19][20] and stab wound-induced brain injury, 21 all of which bear pathological similarities to TBI. Furthermore, a post-mortem study of human brain tissue taken from acute TBI victims reported elevated levels of inflammatory cytokines including GM-CSF, 22 and the modulation of GM-CSF in animal studies has been shown to alter other inflammatory cytokines involved in TBI, including tumor necrosis factor-alpha and interleukin-1 beta.…”
Section: Introductionmentioning
confidence: 99%
“…Protection against paraquat-induced DA neurodegeneration can also be achieved by providing trophic support (intranigral or peripheral injection of GDNF or GM-CSF, respectively), which is reduced upon paraquat treatment (Mangano et al, 2011).…”
Section: Paraquatmentioning
confidence: 99%
“…dose, timing of treatment, species or strain, age of animal, iron accumulation, strain specific gene ontology) can explain contradictory effects observed following treatment with the chemical stressor paraquat in mice. Fei et al, 2008;Cristovao et al, 2009;Fernagut et al, 2009;Mangano et al, 2009Mangano et al, , 2011Watson, 2013;. In order to integrate data on paraquat toxicity from widely different experimental models, ranging from cell cultures to repeat dose animal studies, the concentrations close to the target site were compared by classical approaches of in vitro in vivo extrapolation (IVIVE) based on the available publications.…”
Section: Weight Of Evidence For the Ker Biological Plausibilitymentioning
confidence: 99%
“…Given the involvement of oxidative stress and dopaminergic cell loss in paraquat toxicity, various phytochemicals and other compounds have been studied to abrogate neurotoxic response. [41][42][43][44][45] Maneb (manganese ethylene-bis-dithiocarbamate), is a contact fungicide that synergistically interacts with paraquat to markedly reduce locomotor function and increased striatal terminals and nigral neuronal damage. 46 Such synergistic interactions have been considered for the role in PD etiology and are of interest since they reflect actual human exposures.…”
Section: -4mentioning
confidence: 99%